🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shuaitong Chen

The University of Texas MD Anderson Cancer Center

ORCID: 0009-0003-5047-8280

Also affiliated with Harbin Institute of Technology, Bio-Medical Science (South Korea)

Biochemistry, Genetics and Molecular BiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy”.

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Nature Medicine(2022)10.1038/s41591-022-01696-4

N/A

2.2DataRank · unranked

83 citations

Hui Yang, Feiyang Ma, Guillermo Montalban‐Bravo, Natthakan Thongon, Valentina Marchica +33 more

Hematopoiesis under telomere attrition at the single-cell resolution

Nature Communications(2021)10.1038/s41467-021-27206-7

N/A

0DataRank · unranked

36 citations

Feiyang Ma, Andrea Santoni, Matteo Marchesini, Elena Fiorini, Ashley Rose +20 more

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102253

N/A

0DataRank · unranked

4 citations

Mitsunobu Takeda, Alexey V. Sorokin, Shuaitong Chen, Zecheng Yang, Xiaofei Wang +25 more